SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001079973-11-000639
Filing Date
2011-08-09
Accepted
2011-08-09 16:33:34
Documents
9
Period of Report
2011-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q appy_10q-063011.htm 10-Q 671331
2 EXHIBIT 31.1 ex31x1.htm EX-31.1 14452
3 EXHIBIT 31.2 ex31x2.htm EX-31.2 14971
4 EXHIBIT 32 ex32.htm EX-32 13483
  Complete submission text file 0001079973-11-000639.txt   2380692

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT appyd-20110630.xml EX-101.INS 341894
6 XBRL TAXONOMY EXTENSION SCHEMA appyd-20110630.xsd EX-101.SCH 9608
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE appyd-20110630_cal.xml EX-101.CAL 31450
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE appyd-20110630_lab.xml EX-101.LAB 119544
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE appyd-20110630_pre.xml EX-101.PRE 66506
Mailing Address 1585 S. PERRY STREET CASTLE ROCK CO 80104
Business Address 1585 S. PERRY STREET CASTLE ROCK CO 80104 (303) 794-2000
AspenBio Pharma, Inc. (Filer) CIK: 0001167419 (see all company filings)

IRS No.: 841553387 | State of Incorp.: CO | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33675 | Film No.: 111021292
SIC: 2835 In Vitro & In Vivo Diagnostic Substances